ClinicalTrialsFinder

Recurrent Myeloproliferative Neoplasm Clinical Trials in Houston, Texas

1 recruitingHouston, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations

Myelodysplastic SyndromeRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic Syndrome+3 more
M.D. Anderson Cancer Center58 enrolled1 locationNCT04493138